Navigation Links
Ritter Pharmaceuticals Hires Dr. Howard Foyt as Executive Vice President, Development & Chief Medical Officer
Date:9/10/2009

of gastrointestinal physiology, metabolism and gut adaptation brings creativity to providing unique therapeutic approaches to a variety of GI diseases, including lactose intolerance, irritable bowel syndrome, Crohn's disease, and ulcerative colitis. Ritter's ultimate goal is to improve digestive health and overall quality of life.

Ritter's first compound, RP-G28, has been developed for the treatment of lactose intolerance. RP-G28 will effectively stand out as the first FDA-approved drug for the treatment of lactose intolerance.

www.ritterpharma.com


'/>"/>
SOURCE Ritter Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Reportlinker Adds US and European Radiopharmaceuticals Market Report
2. Cumberland Pharmaceuticals Launches Caldolor(R) in the United States for Treatment of Pain and Fever
3. Isis Pharmaceuticals to Present at Morgan Stanleys Global Healthcare Unplugged Conference
4. Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
5. Jazz Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Amira Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
8. Steven Holtzman Joins Satori Pharmaceuticals Board of Directors
9. Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
10. Peregrine Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2010
11. Isis Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire-FirstCall/--TheAdvisoryBoardCompany(Nasdaq:...tAnnualPiperJaffrayHealthCareConferenceinNewYorkCi...M(EST),willbetheCompany,sChiefExecutiveOfficer,Rob...cer,MichaelT.Kirshbaum.Thepresentationmaterialswil...ww.advisoryboardcompany.com ,throughDecember16,200...
(Date:11/25/2009)...RNewswire/--DanielTouizer,CEOof Ci n e r gyHe...nsurancebenefitprograms,isconcernedthatthelabordep...fiveAmericansarewithoutafull-timejobandunlikelytoh...edeterminedbytheU-6number,whichhasspikedto17.5%,th...izer ."Thesestatisticsarealarmingasitmeansthatman...
(Date:11/25/2009)... Melvin R. Kaplan, MD, FACP, a former Board Chair ...that became Los Angeles Biomedical Research Instit...l be honored by the American College of Physicians.... , At its April 22, 2010 meeting in Toronto, th...Kaplan with the Ralph O. Claypoole Sr. Memorial Aw...
(Date:11/25/2009)... success for patients with liver lesions, research...ay News) -- Adding the drug cetuximab to neoadjuva...ds of successful surgery in colorectal cancer pati... research suggests. , , Tumors spread to other...ith colorectal cancer. Most commonly, the cancer s...
(Date:11/25/2009)...PRNewswire-FirstCall/-- TheProvidenceServiceCorpo...aresubsidiary,thenation,slargestcoordinatorofnon-e...iceofawardfromtheStateofFloridaCommissionfortheTra...encytransportationservicestobothMiami-DadeandVolus...revenueovertheinitial18monthterm,issubjecttofinali...
Breaking Medicine News(10 mins):Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:1 of LA BioMed's founders to be honored 2Health News:Cetuximab Helps Treat Colorectal Cancer 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 2Health News:Providence Service Corporation's LogistiCare Subsidiary Announces Non-Emergency Medical Transportation Contracts Worth Over $11 Million Annually in Florida 3
...r, researchers studying eight cross-gender heart t...overed that the body can actively reshape the hear...tanding belief that the heart cannot repair itself...er organs came after Dr. Federico Quaini and his c...
... amount of fruit and vegetables, but they are stil...ruits and vegetables acts as a booster to our huma...g fruit and veg// at least five times a day increa...ase was from 20 per cent to 25 per cent during thi...
...eath in the United States, after heart disease and...ry year, and 167,000 die from it. Men who suffer f...es as likely// to die from a stroke as other men. ...r 14 years.They found the men with depression or s...
...larly women, may have an increased risk of develop...chers studied almost 100,000 patients who had been... the patients showed any signs of cancer at their ...study’s conclusion, the researchers found that lun...
...rt all reduce the risk of Alzheimer's disease, acc...attainment has already been associated with reduce...eisure activities, too, protect against cognitive ... the participants about their intellectual, social...
...uring her pregnancy, the special form of the disea...and her baby at risk. Moms can develop high blood ...risk for lung problems and occasionally die. To ke... Researchers in Australia and New Zealand found t...
Other Medicine News:
(Date:11/25/2009)...v.25/PRNewswire/--SwissrayInternational,Inc.aleadi...tems,announcedtodaythatitsoperationshavebeenacquir...rowingSwissray,smedicalimagingbrand.Theacquisition...ontractsandinventory.After25yearsofsuccessandgrowt...gicaladvancementswithstableandsteadygrowth. ,, ...
(Date:11/25/2009)...wire/--Reportlinker.comannouncesthatanewmarketrese...asalDrugDelivery-USMarketTrends&Analysis http...elivery---US-Market-Trends--Analysis.html ,, T...nsionoftherapeuticapplicationsfromthedeliveryofcon...mictherapeuticdrugs.Thefutureofthetechnologyhinges...
(Date:11/24/2009)...ewswire/-- ,, WHAT:RomHoubens,aBelgianmanthough...,wasactuallyfullyconsciousandawakeduringthattimean...VoxEyeMaxwasfeaturedinthesegmenttoillustratehowpeo...kcommunication. ,, WHEN:GoodMorningAmerica-- Tu...ech.com ,, WHO:RomHoubenswasanengineeringst...
Breaking Medicine Technology:Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 1BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 2BioNeutrals Ygiene 28TM 29 Hospital Grade Antimicrobial Demonstrates a 99 9997 25 Kill Rate Against Clostridium Difficile Spores 28C diff 29 in Indep 12955 3Questions to Pharmacists Rise After Michael Jacksons Death 51194 1Questions to Pharmacists Rise After Michael Jacksons Death 51194 2IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 1IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors 12952 2
...loping Embryonic Stem Cell Lines for Therapeutic ...C., Jan. 17 A California research team has,become...the cloning of a,human embryo using donated oocyte...onor. The study was published online today by the ....com/cgi-bin/prnh/20080117/CLTH022LOGO ), The ex...
...Vical Incorporated,(Nasdaq: VICL ) today announce...AnGes MG, Inc. for costs associated with the ongoi...c Melanoma (AIMM) Phase 3 trial., AnGes is fundin...er a,previously announced collaborative agreement ...uity investments totaling $22.6 million, for which...
Other Medicine Technology:Study Reports Successful Cloning of Human Embryo Using Adult DNA 2Study Reports Successful Cloning of Human Embryo Using Adult DNA 3Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial 2Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial 3
Coolscope
Eclipse E400
...e the slight change in the difficulty score for ea...orrected visual acuity examinations of 7420 eyes d...lty scores were derived from the examination of 23...letters which resulted in the ultimate homogeneity...
Cube Stereogram Stereo Test
Medicine Products: